Analyst firms · H.C. Wainwright · STTK
H.C. Wainwright STTK price target and rating history
Shattuck Labs Inc. (STTK) · Health Care
H.C. Wainwright rates Shattuck Labs Inc. (STTK) Buy with a $6 price target, as of its latest action on Dec 1, 2025. It has published 3 rating actions on STTK since May 2022, including 1 upgrade and 1 downgrade. Across 6 firms with a STTK price target in the last 12 months, the median target is $16.50. H.C. Wainwright's $6 is 64% below that.
- Current rating
- Buy
- Price target
- $6
- Median target, all firms
- $16.50
- Actions on STTK
- 3
H.C. Wainwright price target on STTK
Every H.C. Wainwright rating on STTK
- Dec 1, 2025
- Oct 1, 2024
- May 2, 2022
How other firms rate STTK
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| UBS | Buy | $17 | Oct 12, 2026 |
| Raymond James | Strong Buy | $18 | Aug 24, 2026 |
| Leerink Partners | Outperform | $16 | Jul 20, 2026 |
| Cantor Fitzgerald | Overweight | Apr 27, 2026 | |
| Needham | Buy | $25 | Mar 6, 2026 |
| Piper Sandler | Overweight | $15 | Jan 28, 2026 |
| H.C. Wainwright | Buy | $6 | Dec 1, 2025 |
Questions about H.C. Wainwright and STTK
- What is H.C. Wainwright's price target for STTK?
- H.C. Wainwright's latest stated price target for Shattuck Labs Inc. (STTK) is $6, from its action on Dec 1, 2025.
- What is H.C. Wainwright's rating on STTK?
- H.C. Wainwright rates STTK Buy, a bullish rating, as of Dec 1, 2025.
- When did H.C. Wainwright last change its view on STTK?
- On Dec 1, 2025, H.C. Wainwright upgrades to Buy from Neutral, price target $6.
- How does H.C. Wainwright's STTK target compare with other analysts?
- Across 6 firms with a STTK price target in the last 12 months, the median target is $16.50. H.C. Wainwright's $6 is 64% below that.
All H.C. Wainwright ratingsSTTK news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.